abstract |
The present invention provides human, humanized and / or chimeric antibodies and fragments, derivatives / conjugates and compositions thereof having specific binding affinity for interleukin-18. The present invention includes the use of these antibodies for the diagnosis and treatment of diseases associated with increased IL-18 activity, in the form of pharmaceutical compositions in therapy. |